001     2667
005     20200402205523.0
024 7 _ |2 pmid
|a pmid:19016284
024 7 _ |2 DOI
|a 10.1002/cmdc.200800273
024 7 _ |2 WOS
|a WOS:000261877100004
024 7 _ |a altmetric:133065
|2 altmetric
037 _ _ |a PreJuSER-2667
041 _ _ |a eng
082 _ _ |a 540
084 _ _ |2 WoS
|a Chemistry, Medicinal
084 _ _ |2 WoS
|a Pharmacology & Pharmacy
100 1 _ |0 P:(DE-HGF)0
|a van Groen, T.
|b 0
245 _ _ |a A Novel D-enantiomeric Peptide Reduces Alzheimer's Disease Amyloid Plaque Load in Transgenic Mice
260 _ _ |a Weinheim [u.a.]
|b Wiley-VCH
|c 2008
300 _ _ |a 1848 - 1852
336 7 _ |a Journal Article
|0 PUB:(DE-HGF)16
|2 PUB:(DE-HGF)
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|0 0
|2 EndNote
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a article
|2 DRIVER
440 _ 0 |0 19901
|a ChemMedChem
|v 3
|x 1860-7179
|y 12
500 _ _ |a This work has been supported by a grant of the Volkswagen-Stiftung to DIN (1/82 649).
536 _ _ |0 G:(DE-Juel1)FUEK409
|2 G:(DE-HGF)
|a Funktion und Dysfunktion des Nervensystems
|c P33
|x 0
588 _ _ |a Dataset connected to Web of Science, Pubmed
650 _ 2 |2 MeSH
|a Alzheimer Disease: pathology
650 _ 2 |2 MeSH
|a Amino Acid Sequence
650 _ 2 |2 MeSH
|a Amyloid beta-Peptides: chemistry
650 _ 2 |2 MeSH
|a Amyloid beta-Peptides: metabolism
650 _ 2 |2 MeSH
|a Animals
650 _ 2 |2 MeSH
|a Disease Models, Animal
650 _ 2 |2 MeSH
|a Mice
650 _ 2 |2 MeSH
|a Mice, Transgenic
650 _ 2 |2 MeSH
|a Oligopeptides: chemistry
650 _ 2 |2 MeSH
|a Oligopeptides: pharmacology
650 _ 2 |2 MeSH
|a Peptide Library
650 _ 2 |2 MeSH
|a Peptides: chemistry
650 _ 2 |2 MeSH
|a Peptides: pharmacology
650 _ 2 |2 MeSH
|a Plaque, Amyloid: drug effects
650 _ 2 |2 MeSH
|a Spectrometry, Fluorescence
650 _ 2 |2 MeSH
|a Stereoisomerism
650 _ 7 |0 0
|2 NLM Chemicals
|a Amyloid beta-Peptides
650 _ 7 |0 0
|2 NLM Chemicals
|a D3 peptide
650 _ 7 |0 0
|2 NLM Chemicals
|a Oligopeptides
650 _ 7 |0 0
|2 NLM Chemicals
|a Peptide Library
650 _ 7 |0 0
|2 NLM Chemicals
|a Peptides
650 _ 7 |2 WoSType
|a J
653 2 0 |2 Author
|a neurochemistry
653 2 0 |2 Author
|a alzheimer's disease
653 2 0 |2 Author
|a therapy
653 2 0 |2 Author
|a peptides
653 2 0 |2 Author
|a phage display
700 1 _ |0 P:(DE-Juel1)VDB15437
|a Wiesehan, K.
|b 1
|u FZJ
700 1 _ |0 P:(DE-Juel1)VDB65869
|a Funke, S. A.
|b 2
|u FZJ
700 1 _ |0 P:(DE-HGF)0
|a Kadish, I.
|b 3
700 1 _ |0 P:(DE-HGF)0
|a Nagel-Steger, L.
|b 4
700 1 _ |0 P:(DE-Juel1)132029
|a Willbold, D.
|b 5
|u FZJ
773 _ _ |0 PERI:(DE-600)2209649-8
|a 10.1002/cmdc.200800273
|g Vol. 3, p. 1848 - 1852
|p 1848 - 1852
|q 3<1848 - 1852
|t ChemMedChem
|v 3
|x 1860-7179
|y 2008
856 7 _ |u http://dx.doi.org/10.1002/cmdc.200800273
909 C O |o oai:juser.fz-juelich.de:2667
|p VDB
913 1 _ |0 G:(DE-Juel1)FUEK409
|a DE-HGF
|b Gesundheit
|k P33
|l Funktion und Dysfunktion des Nervensystems
|v Funktion und Dysfunktion des Nervensystems
|x 0
914 1 _ |y 2008
915 _ _ |0 StatID:(DE-HGF)0010
|a JCR/ISI refereed
920 1 _ |0 I:(DE-Juel1)VDB805
|d 31.12.2008
|g INB
|k INB-2
|l Molekulare Biophysik
|x 0
970 _ _ |a VDB:(DE-Juel1)107786
980 _ _ |a VDB
980 _ _ |a ConvertedRecord
980 _ _ |a journal
980 _ _ |a I:(DE-Juel1)ISB-2-20090406
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-Juel1)ICS-6-20110106
981 _ _ |a I:(DE-Juel1)IBI-7-20200312
981 _ _ |a I:(DE-Juel1)ISB-2-20090406
981 _ _ |a I:(DE-Juel1)ICS-6-20110106


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21